寶勝國際(03813.HK)盈警:預計首季綜合溢利淨額減少超過70%
格隆匯4月29日丨寶勝國際(03813.HK)發佈公吿,集團預期截至2022年3月31日止三個月期間的未經審核綜合營業收入將約為人民幣54.81億元,較2021年同期減少25%。此外,集團預期該期間將錄得未經審核綜合溢利淨額約人民幣1.08億元,較2021年同期的未經審核綜合溢利淨額大幅減少超過70%。
公吿稱,上述該期間的營業收入及溢利淨額預期減少,主要歸因於集團業務營運地區於該期間爆發新一波2019冠狀病毒病疫情,進一步使消費者的消費需求及意欲大幅減低,而且集團營業收入佔比較重的若干業務營運地區的地方重新實施封控措施。因此,集團於該期間的營業收入減少,而集團的業績亦受到不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.